Product Revenues Product Revenues [Abstract] Product Revenues [Abstract] Shares granted, shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Intangible assets Deferred Tax Liabilities, Intangible Assets Document Type Document Type Ifetroban Clinical Ifetroban Clinical [Member] Ifetroban Clinical Exercise of options and related tax benefit, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Net of Shares for Tax Withholding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Net of Shares for Tax Withholding Outstanding, end of period, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Shares Repurchase Activity, Type [Domain] Shares Repurchase Activity, Type [Domain] [Domain] for Shares Repurchase Activity, Type [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Options granted, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Distribution costs Production and Distribution Costs Accounts payable and other current liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Employee Benefit Plans Retirement Benefits [Text Block] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Shares vested, weighted-average grant-date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cumberland Emerging Technologies, Inc (CET) Cumberland Emerging Technologies, Inc [Member] Cumberland Emerging Technologies, Inc [Member] Repurchase of common shares, shares Repurchase of common shares, shares Stock Repurchased During Period, Shares Share-based compensation (foundation contribution) Share-based Compensation, Foundation Contribution Share-based Compensation, Foundation Contribution Numerator: Numerator [Abstract] Numerator. SBA loan pools - variable rate Loan Pools [Member] Loan pools. Licensing Rights Licensing Agreements [Member] Range [Domain] Statistical Measurement [Domain] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Line of Credit Line of Credit [Member] Risks and Uncertainties [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Payments to acquire interest in subsidiaries Payments to Acquire Interest in Subsidiaries and Affiliates Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Security Exchange Name Security Exchange Name Initial public offering, underwriting discounts Stock Issued During Period, New Shares, Underwriting Discounts Stock Issued During Period, New Shares, Underwriting Discounts Operating income (loss) Operating income (loss) Operating Income (Loss) Manufacturing agreements, number of primary suppliers for each product Manufacturing agreements, number of primary suppliers for each product Manufacturing agreements, number of primary suppliers for each product Depreciation, including amortization related to leasehold improvements Depreciation, Including Amortization Related to Leasehold Improvements Depreciation, Including Amortization Related to Leasehold Improvements Total current liabilities Liabilities, Current HongKong WinHealth Pharma Group Co. Limited And DB Pharm Korea Co., Ltd. HongKong WinHealth Pharma Group Co. Limited And DB Pharm Korea Co., Ltd. [Member] HongKong WinHealth Pharma Group Co. Limited And DB Pharm Korea Co., Ltd. Accounts Receivable Accounts Receivable [Policy Text Block] Employment Agreements [Abstract] Employment Agreements [Abstract] Finished goods inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finished Goods Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finished Goods Inventory Prepaid and other current assets Prepaid Expense and Other Assets, Current Nonvested, beginning of period, weighted-average grant-date fair value Nonvested, end of period, weighted-average grant-date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Net cash (used in) operating activities from continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Collaborative Arrangement, Federal Small Business Grant Programs Collaborative Arrangement, Federal Small Business Grant Programs [Member] Collaborative Arrangement, Federal Small Business Grant Programs [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingencies Commitments and Contingencies Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Repurchase of common shares Payments for Repurchase of Common Stock ASSETS Assets [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounting Policies [Abstract] After 2023 Lessee, Operating Lease, Liability, to be Paid, after Year Five Furniture and Fixtures Furniture and Fixtures [Member] Share-based compensation, amount Share-based compensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Entity Address, State or Province Entity Address, State or Province Shares vested, shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Accounts payable Accounts Payable, Current Conversion of intercompany loans payable Intercompany Loans Payable, Converted Amount Intercompany Loans Payable, Converted Amount Retained earnings Retained Earnings (Accumulated Deficit) Operating lease right-of-use assets Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Denominator: Denominator [Abstract] Denominator. 2020 Lessee, Operating Lease, Liability, to be Paid, Year One Outstanding, beginning of period, shares Outstanding, end of period, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2021 - 2029 Expiration, Term Two [Member] Expiration, Term Two [Member] Equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Four Unrecognized compensation cost related to share-based payments Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Sublease income Operating Leases, Rent Expense, Sublease Rentals Financial consideration, payment period Financial Consideration, Payment Period Financial Consideration, Payment Period Major Customers [Axis] Customer [Axis] State and other Current State and Local Tax Expense (Benefit) Change in unpaid invoices for purchases of intangibles Purchases of Intangible Assets Incurred But Not Yet Paid Purchases of Intangible Assets Incurred But Not Yet Paid Earnings (loss) per share attributable to common shareholders-Continuing operations-diluted (in USD per share) Income (Loss) from Continuing Operations, Per Diluted Share Income Taxes Income Tax, Policy [Policy Text Block] Earnings (loss) per share attributable to common shareholders-Discontinued operations-diluted (in USD per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Options, exerciseable, end of period, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Expiration Time Period [Domain] Expiration Time Period [Domain] [Domain] for Expiration Time Period [Axis] Schedule of other long-term liabilities Other Noncurrent Liabilities [Table Text Block] Payments of financing costs Payments of Financing Costs Other long-term liabilities Other Liabilities, Noncurrent, Total Other Liabilities, Noncurrent Deferred tax assets, net Deferred Income Tax Assets, Net Options forfeited or expired, weighted-average exercise price per share (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Marketable securities Marketable Securities, Current Vesting of common stock Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Rebates, product returns, administrative fees and service fees Product Sales-Related Liabilities, Current Product Sales-Related Liabilities, Current Total Lease, Liability Lease, Liability Valuation allowance for deferred tax assets: SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Schedule of intangible assets, useful lives Schedule of Finite-Lived Intangible Assets UseFul Lives [Table Text Block] Schedule of Finite-Lived Intangible Assets UseFul Lives [Table Text Block] Options forfeited or expired, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Other Revenues Other Revenues [Abstract] Other Revenues [Abstract] Inventories, net Total inventories Inventory, Net Revenue from Contract with Customer, Excluding Assessed Tax Revenues Revenue from Contract with Customer, Excluding Assessed Tax Advertising costs Advertising Expense Inventory [Line Items] Inventory [Line Items] Lender Name [Axis] Lender Name [Axis] Net income (loss) from continuing operations Net income (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Amendment Description Amendment Description Sales Revenue, Goods, Gross Sales Revenue, Goods, Gross [Member] Sales Revenue, Goods, Gross [Member] [Member] Net cash paid (refunded) during the year for: Cash Paid During Year For [Abstract] Cash Paid During Year For [Abstract] Vaprisol Vaprisol [Member] Vaprisol [Member] Concentration risk, percentage Concentration Risk, Percentage Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Stock options, expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Statement [Line Items] Statement [Line Items] Stock issued during period, acquisitions (in shares) Stock Issued During Period, Shares, Acquisitions Schedule of anti-dilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Class of Stock [Domain] Class of Stock [Domain] Computer Equipment Computer Equipment [Member] Noncurrent portion of accrued contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Vesting of common stock, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Defined contribution plan, eligibility, minimum employee service time for participation eligibility Defined Contribution Plan, Eligibility, Minimum Employee Service Time for Participation Eligibility Defined Contribution Plan, Eligibility, Minimum Employee Service Time for Participation Eligibility Statement [Table] Statement [Table] Range [Axis] Statistical Measurement [Axis] Common stock, no par value (dollars per share) Common Stock, No Par Value Credit Facility [Axis] Credit Facility [Axis] Text Block [Abstract] Omeclamox-Pak Omeclamox-Pak Omeclamox-Pak [Member] Omeclamox-Pak [Member] Deferred compensation liability Deferred Compensation Liability, Current and Noncurrent Warrants, exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Business Combinations [Abstract] Business Combinations [Abstract] Marketable Securities Marketable Securities, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Operating Lease Liabilities, Payments Due [Abstract] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Increase (Decrease) in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] 2024 and thereafter Finite-Lived Intangible Assets, Amortization Expense, Year Five and After Finite-Lived Intangible Assets, Amortization Expense, Year Five and After Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Debt Debt Disclosure [Text Block] Revenues Disposal Group, Including Discontinued Operation, Revenue Exercisable, end of period, weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable, Current Share Repurchase Program [Domain] Share Repurchase Program [Domain] Increase in goodwill Goodwill, Period Increase (Decrease) Net deferred tax assets, before valuation allowance Net Deferred Tax Assets, Gross Net Deferred Tax Assets, Gross Amendment Flag Amendment Flag Schedule of calculation of numerator and denominator in earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Total future minimum lease payments Operating Leases, Future Minimum Payments Due Pernix Therapeutics Pernix Therapeutics [Member] Pernix Therapeutics [Member] Weighted-average common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer 2 Customer Two [Member] Customer Two [Member] Costs of products sold Disposal Group, Including Discontinued Operation, Costs of Goods Sold Number of shares reserved for issuance under equity compensation plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Research and Development Research and Development Expense, Policy [Policy Text Block] Deferred Tax Assets Deferred Tax Assets, Gross [Abstract] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Accrued payment for asset purchase Accrued Payment For Asset Purchase, Current Accrued Payment For Asset Purchase, Current Total inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Initial public offering, price per share Stock Issued During Period, Price Per Share, New Issues Stock Issued During Period, Price Per Share, New Issues Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Long-Term Incentive Compensation Plan 2007 Long-Term Incentive Compensation Plan 2007 [Member] Long-Term Incentive Compensation Plan 2007 [Member] Schedule of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Geographical [Axis] Geographical [Axis] Subsequent events Subsequent Events [Text Block] Charged to other accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Pinnacle Bank Pinnacle Bank [Member] Pinnacle Bank [Member] Statement of Cash Flows [Abstract] Foundation Contribution Foundation Contribution [Member] Foundation Contribution [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Schedule of restricted stock activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Balance at beginning of period Balance at end of period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Common Stock [Abstract] Common Stock [Abstract] Common Stock [Abstract] Schedule of net product revenues by product Revenue from External Customers by Products and Services [Table Text Block] Accounts receivable, allowances, current Accounts Receivable, Allowance for Credit Loss, Current Stock issued during period, acquisitions Stock Issued During Period, Value, Acquisitions 2021 Lessee, Operating Lease, Liability, to be Paid, Year Two State State and Local Jurisdiction [Member] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Federal Current Federal Tax Expense (Benefit) Stockholders' Equity Note [Abstract] Amortization Amortization of intangible assets Amortization of Intangible Assets Other permanent differences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Line of Credit Facility [Table] Line of Credit Facility [Table] Cumulative upfront payment Revenue Recognition, Cumulative Upfront Payment Revenue Recognition, Cumulative Upfront Payment 2022 Lessee, Operating Lease, Liability, to be Paid, Year Three Other assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Proceeds from sale of common stock, net of offering costs Stock Issued During Period, Value, New Issues Concentration Risk [Table] Concentration Risk [Table] Total assets Assets Consigned inventory Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Written Communications Written Communications Nonvested, beginning of period, shares Nonvested, end of period, shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Title of 12(b) Security Title of 12(b) Security Schedule of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] Intangible assets, net Intangible assets, net Finite-Lived Intangible Assets, Net Subsequent Event Type [Axis] Subsequent Event Type [Axis] Share Repurchase Program Authorized in 2010 Share Repurchase Program Authorized in 2010 [Member] Share Repurchase Program Authorized in 2010 [Member] Deferred offering costs included in accounts payable and other accrued expenses Deferred Offering Costs Included in Accounts Payable and Other Accrued Expenses Deferred Offering Costs Included in Accounts Payable and Other Accrued Expenses Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Interest expense Interest Expense Raw materials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Raw Materials Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Raw Materials Inventory Vibativ Product, Vibativ [Member] Product, Vibativ Depreciation and amortization expense Depreciation, Depletion and Amortization Schedule of the components of income tax benefit (expense) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of rent expense and sublease income Schedule of Rent Expense and Sublease Income [Table Text Block] Schedule of Rent Expense and Sublease Income [Table Text Block] Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Manufacturing and Supply Agreement [Table] Manufacturing and Supply Agreement [Table] Manufacturing and Supply Agreement [Table] Prepaid and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Unrecognized compensation cost related to share-based payments, period for recognition Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Less Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Non-US Non-US [Member] Pre-commencement Tender Offer Pre-commencement Tender Offer Additions to intangible assets from final purchase price allocation Noncash or Part Noncash Acquisition, Intangible Assets Acquired Commitments and Contingencies Disclosure [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Decrease in non-cash contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset Inventories Increase (Decrease) in Inventories Excess tax (benefit) expense derived from exercise of stock options Excess Tax Benefit from Share-based Compensation, Operating Activities Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Accounts Receivable, Allowances by Component [Domain] Accounts Receivable, Allowances by Component [Domain] [Domain] for Accounts Receivable, Allowances by Component [Axis] Number of shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Raw materials and work in process Inventory, Raw Materials, Net of Reserves Schedule of federal and state net operating loss carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Exercise of options and related tax benefit Noncontrolling Interest, Increase from Sale of Parent Equity Interest Total inventories Inventory, Gross Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of quarterly financial information Quarterly Financial Information [Table Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Asset Class [Axis] Asset Class [Axis] Adjustments to reconcile net income (loss) to net cash flows provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Earnings (loss) per share attributable to common shareholders-Continuing operations-basic (in USD per share) Income (Loss) from Continuing Operations, Per Basic Share Future minimum sublease income under noncancelable operating subleases Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Repurchase of subsidiary shares from noncontrolling interests Repurchase of subsidiary shares to noncontrolling interest Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Inventory Deferred Tax Assets, Inventory Entity Information [Line Items] Entity Information [Line Items] Common stock, number of shares outstanding Equity, common shares outstanding Equity, common shares outstanding Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Deferred Compensation Arrangements [Abstract] Deferred Compensation Liability [Abstract] Milestone payments associated with international agreements Revenue Recognition, Milestone Payments Revenue Recognition, Milestone Payments Revolving Credit Facility Revolving Credit Facility [Member] Research and development Research and Development Expense Employment Agreements Employment Agreements [Text Block] Employment Agreements Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Subsequent Event Subsequent Event [Member] Outstanding, beginning of period, weighted-average exercise price per share (in USD per share) Outstanding, end of period, weighted-average exercise price per share (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Shares Repurchase, All, Except Settlement of Tax Liabilities Related to Exercise of Stock Options Shares Repurchase, All, Except Settlement of Tax Liabilities Related to Exercise of Stock Options [Member] Shares Repurchase, All, Except Settlement of Tax Liabilities Related to Exercise of Stock Options [Member] Common stock, number of shares authorized Common Stock, Shares Authorized Concentration Risk Type [Axis] Concentration Risk Type [Axis] Leases Leases of Lessee Disclosure [Text Block] Deferred charges Deferred Tax Assets, Deferred Charges Deferred Tax Assets, Deferred Charges Dilutive effect of restricted stock and stock options (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Property and equipment, gross Property, Plant and Equipment, Gross Sales of shares of common stock, net of offering costs Proceeds from Stock Options Exercised Federal Deferred Federal Income Tax Expense (Benefit) Methotrexate Methotrexate [Member] Methotrexate [Member] Expiration Time Period [Axis] Expiration Time Period [Axis] Expiration Time Period [Axis] Principal Owner Principal Owner [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Liabilities incurred Business Combination, Consideration Transferred, Liabilities Incurred Income Statement [Abstract] Initial public offering, gross proceeds Stock Issued During Period, Gross Proceeds from Initial Public Offering Stock Issued During Period, Gross Proceeds from Initial Public Offering Operating Lease, Liability, Noncurrent Operating lease liabilities Operating Lease, Liability, Noncurrent 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Four Rent expense Operating Leases, Rent Expense Intellectual property amortizable intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Weighted-average fair value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Grant Date Fair Value Discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Use of Estimates Use of Estimates, Policy [Policy Text Block] Permanent differences associated with general business credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Current assets: Assets, Current [Abstract] Other revenue, upfront payment Revenue Recognition, Upfront Payment Revenue Recognition, Upfront Payment Interest income Investment Income, Interest Income Tax Authority [Domain] Income Tax Authority [Domain] Amount available under current repurchase program Stock Repurchase Program, Remaining Authorized Repurchase Amount Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Revolving line of credit Long-term Line of Credit, Noncurrent Deferred income tax (expense) benefit Deferred Other Tax Expense (Benefit) Patents Patents [Member] Total Lease, Asset Lease, Asset Schedule of effective tax rate reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Fair value of contingent consideration - net sales royalty Payments for Contingent Consideration Payments for Contingent Consideration Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Allowance for accounts receivable Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Counterparty Name [Domain] Counterparty Name [Domain] Legal Entity [Axis] Legal Entity [Axis] Additions to property and equipment Payments to Acquire Property, Plant, and Equipment City Area Code City Area Code Soliciting Material Soliciting Material Stock options, exercise price as percent of weighted-average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price as Percent of Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price as Percent of Weighted Average Grant Date Fair Value Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Gloria Pharmaceuticals Gloria Pharmaceuticals [Member] Gloria Pharmaceuticals Liability to be paid Balance at November 12, 2018 Balance at December 31, 2018 Business Combination, Contingent Consideration, Liability Other revenue, potential upfront payment related to product sales Revenue Recognition, Potential Upfront Payment Related to Product Sales Revenue Recognition, Potential Upfront Payment Related to Product Sales Net tax benefit, impact of Tax Act Tax Cuts and Jobs Act, Income Tax Expense (Benefit) Property, Plant and Equipment [Abstract] Director Director [Member] Share repurchase program, number of shares authorized to be repurchased Stock Repurchase Program, Authorized Amount Other Current and Other Long-term Liabilities Other Liabilities Disclosure [Text Block] Net income (loss) Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income (loss) before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Manufacturing and Supply Agreements Manufacturing and Supply Agreements [Text Block] Manufacturing and Supply Agreements Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Quarterly Financial Information Disclosure [Abstract] Schedule of inventories, current Schedule of Inventory, Current [Table Text Block] Accounts receivable Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Fair value of marketable securities Debt Securities, Trading, and Equity Securities, FV-NI Repurchase of common shares Repurchase of common shares, value Stock Repurchased During Period, Value Share-based compensation Share-based Payment Arrangement, Noncash Expense Caldolor Caldolor [Member] Caldolor. Entity [Domain] Entity [Domain] Number of equity compensation plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Non-current inventories less non-current inventories Inventory, Noncurrent Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Net loss at subsidiary attributable to noncontrolling interests Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Quarterly Financial Information (Unaudited) Quarterly Financial Information [Text Block] Vesting of shares related to RediTrex approval Noncash or Part Noncash Transaction, Vesting of Shares Noncash or Part Noncash Transaction, Vesting of Shares Intangible Assets Intangible Assets Disclosure [Text Block] Property and equipment, useful life Property, Plant and Equipment, Useful Life After 2023 Operating Leases, Future Minimum Payments, Due Thereafter Increase in valuation allowance during the year SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) Fair Value Disclosures [Abstract] 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months Noncash investment gains Other Nonoperating Gains (Losses) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Net deferred tax assets Deferred Tax Assets, Net Charitable contribution of shares, shares Share-based Compensation, Charitable Contribution of Shares, Shares Share-based Compensation, Charitable Contribution of Shares, Shares Cost of products sold Cost of Goods and Services Sold Total costs and expenses Costs and Expenses Equity Components [Axis] Equity Components [Axis] Restricted Stock Restricted Stock [Member] Finished goods, net of reserve Finished goods Inventory, Finished Goods, Net of Reserves Work in process - unlabeled vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Unlabeled Vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Unlabeled Vials Share-based Payment Arrangement [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Borrowings on line of credit Proceeds from (Repayments of) Lines of Credit Total deferred tax assets Deferred Tax Assets, Gross Minimum Minimum [Member] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Repayments on line of credit Repayments of Notes Payable Operating lease current liabilities Operating lease liabilities Operating Lease, Liability, Current Acetadote Acetadote [Member] Acetadote. Product Sales Related Allowances - Chargebacks, Cash Discounts and Damaged Goods Chargebacks, Cash Discounts and Damaged Goods [Member] Chargebacks, Cash Discounts and Damaged Goods [Member] Schedule of Business Acquisitions by Acquisition, Contingent Consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Net loss at subsidiary attributable to noncontrolling interests Net loss at subsidiary attributable to noncontrolling interests Net loss at subsidiary allocated to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Manufacturing and Supply Agreements [Abstract] Manufacturing and Supply Agreements [Abstract] Shares forfeited, weighted-average grant-date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Options exercised, weighted-average exercise price per share (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Revenues: Revenues [Abstract] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Initial public offering, effective date Sale of Stock, Transaction Date Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Schedule of stock options activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Accounts Receivable Accounts Receivable [Member] Share-Based Payments Share-based Payment Arrangement [Policy Text Block] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Name of Major Customer [Domain] Customer [Domain] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Disposal Group, Including Discontinued Operation, Assets, Current Current assets associated with discontinued operations Disposal Group, Including Discontinued Operation, Assets, Current Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Entity Registrant Name Entity Registrant Name Warrants, Issued in Consideration of 2009 Credit Facility Amendment Warrants, Issued in Consideration of 2009 Credit Facility Amendment [Member] Warrants, Issued in Consideration of 2009 Credit Facility Amendment [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] 2020 Expiration, Term One [Member] Expiration, Term One [Member] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Statement of Stockholders' Equity [Abstract] Concentration Risk [Line Items] Concentration Risk [Line Items] Weighted-average incremental borrowing rate Operating Lease, Weighted Average Discount Rate, Percent Adjustment to initial fair value of the contingent consideration liability Business Combination, Contingent Consideration Arrangements, Contingent Consideration, Liability, Initial Fair Value Adjustment Business Combination, Contingent Consideration Arrangements, Contingent Consideration, Liability, Initial Fair Value Adjustment Advertising Costs Advertising Cost [Policy Text Block] Employee, Nonemployee and Foundation Contribution Employee, Nonemployee and Foundation Contribution [Member] Employee, Nonemployee and Foundation Contribution [Member] Grant Grant [Member] Weighted-average exercise price per share Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Change in fair value of contingent consideration included in operating expenses Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Charged to costs and expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Shares Repurchase Activity, Type [Axis] Shares Repurchase Activity, Type [Axis] Shares Repurchase Activity, Type [Axis] Non cash increase in liabilities related to acquisition (see Note 3) Noncash or Part Noncash Acquisition, Other Liabilities Assumed VIBATIV VIBATIV [Member] VIBATIV Remaining inventory Disposal Group, Including Discontinued Operation, Remaining Inventory, Current Disposal Group, Including Discontinued Operation, Remaining Inventory, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Accounts receivable, net of allowances Accounts Receivable, after Allowance for Credit Loss, Current Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Noncontrolling interest, ownership percentage by parent Noncontrolling Interest, Ownership Percentage by Parent Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Customer 1 Customer One [Member] Customer One [Member] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trademarks Trademarks [Member] Intangible assets, useful life Finite-Lived Intangible Assets, Useful Lives, (Textual) Finite-Lived Intangible Assets, Useful Lives, (Textual) Goodwill Goodwill Title of Individual [Axis] Title of Individual [Axis] Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Current portion of accrued contingent consideration Business Combination, Contingent Consideration, Liability, Current Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] HongKong WinHealth Pharma Group Co. Limited HongKong WinHealth Pharma Group Co. Limited [Member] HongKong WinHealth Pharma Group Co. Limited Other revenue, potential upfront payments related to regulatory approval Revenue Recognition, Potential Upfront Payments Related to Regulatory Approval Revenue Recognition, Potential Upfront Payments Related to Regulatory Approval Nonemployee Nonemployee [Member] Nonemployee [Member] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Reserve for expired product Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves for Expired Product Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves for Expired Product Investment in CET Subsidiary Investment, Purchase Of Shares Subsidiary Investment, Purchase Of Shares Level 2 Fair Value, Inputs, Level 2 [Member] Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Second Amendment Second Amendment [Member] Second Amendment Fair Value by Asset Class [Domain] Asset Class [Domain] Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Earnings (loss) per share attributable to common shareholders-Discontinued operations-basic (in USD per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Revenues Additional Financial Information Disclosure [Text Block] Options granted, weighted-average exercise price per share (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Entities [Table] Entities [Table] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Customer Concentration Risk Customer Concentration Risk [Member] Credit Facility [Domain] Credit Facility [Domain] Amended International Agreement Amended International Agreement [Member] Amended International Agreement [Member] Schedule of expected amortization expense of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Diluted (in shares) Weighted-average shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of fair value of financial instruments by level in hierarchy Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Basic (in USD per share) Earnings Per Share, Basic Number of equity compensation plans available for future grants Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Available for Future Grants Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Available for Future Grants Number of operating segments Number of Operating Segments Entity File Number Entity File Number Shares forfeited, shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Inventory, Current [Table] Inventory, Current [Table] Selling and marketing Selling and Marketing Expense Discontinued operations net of tax Net income (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Common stock – no par value; 100,000,000 shares authorized; 15,263,555 and 15,481,497 shares issued and outstanding as of December 31, 2019 and 2018, respectively Common Stock, Value, Outstanding Other current liabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Current Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Sale of subsidiary shares to noncontrolling interest Proceeds from Noncontrolling Interests Inventory reserves, obsolescence and discontinuance Inventory Valuation Reserves Revenue from External Customers by Products and Services [Table] Products and Services [Table] Committed cash contributions Share-based Compensation, Charitable Contribution of Shares, Committed Cash Contributions Share-based Compensation, Charitable Contribution of Shares, Committed Cash Contributions Counterparty Name [Axis] Counterparty Name [Axis] Change in tax rate Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent Defined contribution plan, eligibiilty, minimum employee age Defined Contribution Plan, Eligibility, Minimum Employee Age Defined Contribution Plan, Eligibility, Minimum Employee Age Goodwill and Intangible Assets Disclosure [Abstract] Payments for asset acquisitions Payments for Asset Acquisitions Payments for Asset Acquisitions Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] 2021 Finite-Lived Intangible Asset, Expected Amortization, Year Two Commercial Paper Commercial Paper [Member] Exercisable, end of period, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Deferred compensation assets Deferred Compensation Plan Assets Inventory Disposal Group, Including Discontinued Operation, Inventory, Current Retirement Benefits [Abstract] Schedule of depreciation expense Schedule of Depreciation Expense [Table Text Block] Schedule of Depreciation Expense [Table Text Block] Cash payment of royalty during the period Payments for Royalties Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Share-based compensation, shares Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Comprehensive income (loss) attributable to common shareholders Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Shares granted, weighted-average grant-date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Inventory Disclosure [Abstract] Customer 3 Customer Three [Member] Customer Three [Member] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock, number of shares issued Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Contribution of cash Contribution of Cash, Additional Shares Purchased Contribution of Cash, Additional Shares Purchased Property and equipment, useful life (Textual) Property and Equipment, useful life (Textual) Property and Equipment, useful life (Textual) Present value of lease liabilities Operating Lease, Liability Segment Reporting [Abstract] Segment Reporting [Abstract] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Total shareholders’ equity Stockholders' Equity Attributable to Parent U.S. Treasury notes and bonds US Treasury Notes And Bonds Securities [Member] US Treasury Notes And Bonds Securities Tiered royalty payments (percentage) Tiered Royalty Payments, Percentage Tiered Royalty Payments, Percentage Disposal Group, Including Discontinued Operation, Liabilities, Current Current liabilities associated with discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Payments of deferred equity offering costs Initial public offering, issuance costs Payments of Stock Issuance Costs Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total consideration Business Combination, Consideration Transferred Net operating loss and tax credits Deferred Tax Assets, Operating Loss Carryforwards and Tax Credit Carryforwards Deferred Tax Assets, Operating Loss Carryforwards and Tax Credit Carryforwards Total liabilities and equity Liabilities and Equity Selling, Marketing and other Disposal Group, Including Discontinued Operation, General and Administrative Expense Income Taxes Income Tax Disclosure [Text Block] Entity Address, City or Town Entity Address, City or Town Schedule of revenues concentration from major customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Employee wages and benefits Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Additions to intangible assets Additions to intangible assets Payments to Acquire Intangible Assets Accounts Receivable, Allowances by Component [Axis] Accounts Receivable, Allowances by Component [Axis] Accounts Receivable, Allowances by Component [Axis] General and administrative General and Administrative Expense Deferred Tax Liabilities Deferred Tax Liabilities, Gross [Abstract] Line of credit, maximum borrowing capacity upon satisfaction of certain conditions Line of Credit Facility, Maximum Borrowing Capacity Upon Satisfaction of Certain Conditions Line of Credit Facility, Maximum Borrowing Capacity Upon Satisfaction of Certain Conditions 2022 Operating Leases, Future Minimum Payments, Due in Four Years Anti-dilutive shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total current income tax (expense) benefit Current Income Tax Expense (Benefit) Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Product Product [Member] Equity Component [Domain] Equity Component [Domain] Valuation allowance Less: deferred tax asset valuation allowance Deferred Tax Assets, Valuation Allowance Kristalose Kristalose [Member] Kristalose. Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Preferred Stock [Abstract] Preferred Stock [Abstract] Preferred Stock [Abstract] 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Three Entity Tax Identification Number Entity Tax Identification Number Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Deferred compensation Deferred Compensation Liability, Classified, Noncurrent Stock-Based Compensation Plans Share-based Payment Arrangement [Text Block] Net income (loss) attributable to common shareholders Net income (loss) attributable to common shareholders Net Income (Loss) Attributable to Parent Net changes in assets and liabilities affecting operating activities: Increase (Decrease) in Operating Capital [Abstract] Other Other Liabilities, Current Warrants, Issued in Consideration of 2006 Credit Facility Amendment Warrants, Issued in Consideration of 2006 Credit Facility Amendment [Member] Warrants, Issued in Consideration of 2006 Credit Facility Amendment [Member] Inventories Inventory Disclosure [Text Block] Schedule of balance sheet classification Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Total intangibles and goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles and Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles and Goodwill Leases [Abstract] Total current assets Assets, Current Operating loss carryforwards Operating Loss Carryforwards Other Liabilities, Current [Abstract] Earnings (loss) per share attributable to common shareholders: Earnings per share attributable to common shareholders Earnings Per Share [Abstract] Schedule of deferred tax assets and liabilities, net Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Directors’ Incentive Plan 2007 Directors’ Incentive Plan 2007 [Member] Directors’ Incentive Plan 2007 [Member] State income tax expense (net of federal income tax benefit) Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Manufacturing and Supply Agreement [Line Items] Manufacturing and Supply Agreement [Line Items] [Line Items] for Manufacturing and Supply Agreement [Table] NonPrincipal Owner NonPrincipal Owner [Member] NonPrincipal Owner [Member] Sale of subsidiary shares to noncontrolling interest Noncontrolling Interest, Increase from Subsidiary Equity Issuance Shareholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Warrants, number of shares called by warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Proceeds from sale of marketable securities Proceeds from Sale of Short-term Investments Product and License Rights Product and License Rights [Member] Product and License Rights [Member] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Other Accounts Payable and Accrued Liabilities, Noncurrent Product Rights Product Rights [Member] Product Rights [Member] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Schedule of share-based compensation expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Common stock Common Stock [Member] Stock payable Accrued Liabilities, Stock Payable Accrued Liabilities, Stock Payable Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Product and Service [Domain] Product and Service [Domain] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Allowance for uncollectible amounts, cash discounts, chargebacks, and credits issued for damaged products: SEC Schedule, 12-09, Allowance, Credit Loss [Member] Financial consideration Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset Exchange for consideration, amount Subsidiary Investment, Payments For Return Of Capital Subsidiary Investment, Payments For Return Of Capital Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Proceeds from the sale of common stock, net of offering costs, shares Initial public offering, shares issued Stock Issued During Period, Shares, New Issues Class of Treasury Stock [Table] Class of Treasury Stock [Table] Schedule of stock options activity, additional disclosures Schedule of Stock Option Activity, Additional Disclosures [Table Text Block] Schedule of Stock Option Activity, Additional Disclosures [Table Text Block] Leasehold Improvements Leasehold Improvements [Member] Collaborative Agreements Collaborative Arrangement, Accounting Policy [Policy Text Block] Intangible assets, gross Finite-Lived Intangible Assets, Gross Interest rate Debt Instrument, Interest Rate, Stated Percentage Short-term cash investments Municipal Bonds [Member] Other Manufactured Product, Other [Member] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Nordic Nordic [Member] Nordic Options exercised, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Omeclamox®-Pak, RediTrex® and Vibativ® Business Combination Disclosure [Text Block] Loans Forgiven in Exchange For Share Issued, Amount Loans Forgiven in Exchange For Share Issued, Amount Loans Forgiven in Exchange For Share Issued, Amount Harbin Gloria Pharmaceuticals Co Harbin Gloria Pharmaceuticals Co [Member] Harbin Gloria Pharmaceuticals Co [Member] Schedule of operating lease liability maturities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Stock Options Share-based Payment Arrangement, Option [Member] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Accrued inventory purchases Accrued Liabilities, Inventory Purchases Accrued Liabilities, Inventory Purchases Basic (in shares) Weighted-average shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Costs and expenses: Costs and Expenses [Abstract] Subsequent Events [Abstract] Ownership [Axis] Ownership [Axis] Initial public offering, number of shares common stock received in exchange for preferred stock Stock Issued in Initial Public Offering, Number of Shares Common Stock Received for Preferred Stock Contemporareous With Offering Stock Issued in Initial Public Offering, Number of Shares Common Stock Received for Preferred Stock Contemporareous With Offering State Deferred State and Local Income Tax Expense (Benefit) Schedule of future minimum lease payments for operating leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Ownership [Domain] Ownership [Domain] Plan Name [Domain] Plan Name [Domain] Employee Employee [Member] Employee [Member] 2031 - 2039 Expiration, Term Four [Member] Expiration, Term Four [Member] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Contingent consideration earned and accrued in operating expenses Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses Total equity Equity, balance Equity, balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Recognition of operating lease assets and liabilities through adoption of ASC 842 Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Initial public offering, net proceeds Proceeds from Issuance Initial Public Offering 2020 Finite-Lived Intangible Asset, Expected Amortization, Year One Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Revenues Net revenues from customers outside the United States Revenues 2021 Operating Leases, Future Minimum Payments, Due in Three Years Class of Stock [Axis] Class of Stock [Axis] Inventories Inventory, Policy [Policy Text Block] Income tax (expense) benefit Total income tax (expense) benefit Income Tax Expense (Benefit) 2023 Operating Leases, Future Minimum Payments, Due in Five Years Income taxes Income Taxes Paid, Net Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Defined contribution plan, employer discretionary contribution amount Defined Contribution Plan, Employer Discretionary Contribution Amount Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Purchases of marketable securities Payments to Acquire Marketable Securities Title of Individual with Relationship to Entity [Domain] Title of Individual [Domain] Other current liabilities Total other current liabilities Accrued Liabilities, Current Diluted (in USD per share) Earnings Per Share, Diluted 2020 Operating Leases, Future Minimum Payments, Due in Two Years Local Phone Number Local Phone Number Work in process - validation vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Validation Vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Validation Vials Cash paid for acquisition Payments to acquire businesses Cash paid at closing Payments to Acquire Businesses, Gross Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Income from discontinued operations Disposal Group, Including Discontinued Operation, Operating Income (Loss) Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangements and Non-collaborative Arrangements [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Revaluation of deferred income tax balances for new rates under TCJA Tax Cuts and Jobs Act of 2017, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense (Benefit) Tax Cuts and Jobs Act of 2017, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense (Benefit) Contingent consideration liability Change in Contingent Consideration [Heading Roll Forward] Change in Contingent Consideration Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Prepaid, other current assets and other assets Increase (Decrease) in Other Operating Assets Entity Emerging Growth Company Entity Emerging Growth Company Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Exercise of options and related tax benefit Stock Issued During Period, Value, Stock Options Exercised Additional payments to acquire businesses Cash payment during early 2019 Other Payments to Acquire Businesses Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Deferred tax expense Deferred Income Tax Expense (Benefit) Initial Public Offering [Abstract] Initial Public Offering [Abstract] Initial Public Offering [Abstract] Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Federal Internal Revenue Service (IRS) [Member] Award Type [Axis] Award Type [Axis] Weighted- average grant-date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Maximum Maximum [Member] Noncash interest expense Amortization of Debt Issuance Costs Preferred stock, shares authorized Preferred Stock, Shares Authorized Noncontrolling interest Noncontrolling Interest [Member] Cumulative compensation costs incurred on deductible equity awards Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Retained earnings Retained Earnings [Member] Indefinite Period Indefinite [Member] Indefinite Prepaid and Other Current Assets Prepaids and Other Current Assets, Policy [Policy Text Block] Prepaids and Other Current Assets, Policy [Policy Text Block] Cash payments of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Deferred acquisition liability Deferred Acquisition Liability, Current Deferred Acquisition Liability, Current Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net income tax expense Effective Income Tax Rate Reconciliation, Percent Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Market Concentrations Concentration Risk Disclosure [Text Block] Outstanding, end of period, weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] 2030 Expiration, Term Three [Member] Expiration, Term Three [Member] Property and equipment and intangibles Deferred Tax Assets, Property and Equipment and Intangibles Deferred Tax Assets, Property and Equipment and Intangibles Equity Award [Domain] Award Type [Domain] Trading Symbol Trading Symbol Exercisable, end of period, weighted-average exercise price per share (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Discontinued Operations and Disposal Groups [Abstract] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Line of credit, unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Earnings (loss) per Share Earnings Per Share [Text Block] Office Equipment Office Equipment [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Current liabilities: Liabilities, Current [Abstract] Federal tax expense at statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Shelf Registration, sale of corporate securities (up to) Stock Issued During Period, Shelf Registration, Proceeds From Sale of Corporate Securities Stock Issued During Period, Shelf Registration, Proceeds From Sale of Corporate Securities Segment Reporting Segment Reporting, Policy [Policy Text Block] Recent Accounting Guidance New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract]